Acutus Medical, Inc. (NASDAQ: AFIB) reported Q1 EPS of ($0.57), $0.10 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.87 million.

GUIDANCE:

Acutus Medical, Inc. sees FY2023 revenue of $19-21 million, versus the consensus of $19.6 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.